Real-World Safety Of Pemetrexed, Carboplatin, And Pembrolizumab In Us Nsclc Patients
JOURNAL OF CLINICAL ONCOLOGY(2020)
摘要
50Background: A Phase 3 KEYNOTE-189 clinical trial showed improved clinical benefit with acceptable toxicity of pemetrexed combined with pembrolizumab and platinum (Gandhi, 2018). However, the safe...
更多查看译文
关键词
pembrolizumab,carboplatin,pemetrexed,nsclc,real-world
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要